Ilaria Ferlenghi (Current Associate Director of Research & Senior Scientific Leader, GSK and former Predoctoral Fellow, EMBL Heidelberg, 1994-1999) chats with Thomas Vaccari (Current Professor, University of Milan
and former Predoctoral Fellow, EMBL Heidelberg, 1999-2004). Ilaria discusses the future of vaccine development, emphasising the need for tailor-made vaccines for different pathogens and the role of structural biology
This conversation was recorded in February 2026.
A full podcast of this Alumni Chat is available:
Apple Podcasts – https://podcasts.apple.com/de/podcast/the-european-molecular-biology-laboratory-embl-alumni/id1844364990?l=en-GB
Spotify Podcasts – https://open.spotify.com/show/2NikvEB7FNdqw18SaduIjF?si=db15584779b9460e
RSS Feed – https://rss.com/podcasts/the-european-molecular-biology-laboratory-embl-alumni-chats-series/
Alumni Chat contributors are members of the European Molecular Biology Laboratory (EMBL) community. The opinions expressed are their own and are not necessarily representative of the views of EMBL or any other party. The mere appearance of content on EMBL Alumni media accounts does not constitute an endorsement by EMBL.
Production and Editing: EMBL Alumni Relations
Content and Interviews: Angus Lamond and Thomas Vaccari
Music: Eco Technology by Aleksey Chistilin from Pixabay
Thanks to: EMBL Audiovisual and EMBL Design
Sponsored by: EMBLEM © European Molecular Biology Laboratory (EMBL)
source
Leave a Reply